Similar articles for PMID: 19564413

Year	Number of Results
1993	2
1994	3
1995	3
1996	3
1997	10
1998	4
1999	5
2000	5
2001	6
2002	10
2003	2
2004	2
2005	4
2006	1
2007	3
2008	4
2009	10
2010	14
2011	11
2012	12
2013	14
2014	10
2015	2
2016	2
2017	4
2018	6
2019	3
2020	3
2021	2
2022	2
2024	0

1

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, Musgrove EA. Caldon CE, et al. Mol Cell Biol. 2009 Sep;29(17):4623-39. doi: 10.1128/MCB.00269-09. Epub 2009 Jun 29. Mol Cell Biol. 2009. PMID: 19564413 Free PMC article.

2

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL. Prall OW, et al. Mol Cell Biol. 1998 Aug;18(8):4499-508. doi: 10.1128/MCB.18.8.4499. Mol Cell Biol. 1998. PMID: 9671459 Free PMC article.

3

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Doisneau-Sixou SF, et al. Endocr Relat Cancer. 2003 Jun;10(2):179-86. doi: 10.1677/erc.0.0100179. Endocr Relat Cancer. 2003. PMID: 12790780 Review.

4

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL. Carroll JS, et al. Cancer Res. 2002 Jun 1;62(11):3126-31. Cancer Res. 2002. PMID: 12036924

5

A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.

Carroll JS, Prall OW, Musgrove EA, Sutherland RL. Carroll JS, et al. J Biol Chem. 2000 Dec 8;275(49):38221-9. doi: 10.1074/jbc.M004424200. J Biol Chem. 2000. PMID: 10991938 Free article.

6

Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J. Foster JS, et al. Mol Cell Biol. 2001 Feb;21(3):794-810. doi: 10.1128/MCB.21.3.794-810.2001. Mol Cell Biol. 2001. PMID: 11154267 Free PMC article.

7

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL. Prall OW, et al. J Biol Chem. 1997 Apr 18;272(16):10882-94. doi: 10.1074/jbc.272.16.10882. J Biol Chem. 1997. PMID: 9099745 Free article.

8

The requirement for cyclin E in c-Myc overexpressing breast cancers.

Zhou Y, Geng Y, Zhang Y, Zhou Y, Chu C, Sharma S, Fassl A, Butter D, Sicinski P. Zhou Y, et al. Cell Cycle. 2020 Oct;19(20):2589-2599. doi: 10.1080/15384101.2020.1804720. Epub 2020 Sep 25. Cell Cycle. 2020. PMID: 32975478 Free PMC article.

9

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. Perez-Roger I, et al. EMBO J. 1999 Oct 1;18(19):5310-20. doi: 10.1093/emboj/18.19.5310. EMBO J. 1999. PMID: 10508164 Free PMC article.

10

CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.

Lee AW, Nambirajan S, Moffat JG. Lee AW, et al. Oncogene. 1999 Dec 9;18(52):7477-94. doi: 10.1038/sj.onc.1203123. Oncogene. 1999. PMID: 10602507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year